Drug
Gt101
Gt101: highest development phase Phase 2, developed by Grit Biotechnology. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Grit Biotechnology
Trials
| Drug | Phase | Indication |
|---|---|---|
| GT101 NCT06241781 | Phase 2 | Recurrent or Metastatic Cervical Cancer |
Latest
No recent events.
Follow Gt101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.